Pituitary Hormonal Status after Endoscopic Endonasal Transphenoidal Removal of Nonfunctioning Pituitary Adenoma: 5 years' Experience in a Single Center.

BACKGROUND: This study focuses on hormonal disorder and medical complications postoperative endoscopic endonasal transsphenoidal approach of nonfunctioning adenoma at Prasat Neurological Institute, Bangkok, between January 2013 and December 2017. METHODS AND MATERIAL: Baseline characteristics, clinical complications, and hormonal status data were collected from the patients' medical records and analyzed using the descriptive statistics. RESULTS: There were four surgeons who operated 126 cases, 17 of them were reoperation. The average age of the patients was 49 years old. The average length of stay was 13 days, and average operating time was 134 min. Visual field defect was the most common presenting symptom. Almost all the tumors were classified as pituitary macroadenoma which invaded one or two sellar walls. Total or near total tumor removal was the most extend of resection. There were 61 cases developed early diabetes insipidus (DI), but only 12 cases continue to long-term DI. Seven cases were meningitis. Three cases were death. Out of 83 patients who had preoperative intact hypothalamic-pituitary-adrenal (HPA) axis and hypothalamic pituitary thyroidal (HPT) axis, 2 and 3 of them developed postoperative impair HPA and HPT axis in that order. In addition, among 45 patients who had preoperative impair HPA and HPT axis, 6 of them achieved postoperative endocrinological normalization. CONCLUSION: In preoperative intact pituitary hormone patients, the total or near total tumor removal of non functioning pituitary adenoma may have hypopituitarism during early postoperative period but gradually returned to normal during 4-6 month postoperative period.

A comparative study of visual evoked potentials in optic neuritis and optic neuritis with multiple sclerosis.

OBJECTIVE: To compare the visual evoked potentials (VEP) in patients with acute optic neuritis, recurrent optic neuritis, and optic neuritis with multiple sclerosis. MATERIAL AND METHOD: The authors retrospectively reviewed VEP latency records of the patients with optic neuritis in Siriraj Hospital from 1995 to 2005 and divided them into three groups, acute optic neuritis, recurrent optic neuritis, and optic neuritis with multiple sclerosis (ON/MS). The patients with non-recordable VEP in the analysis were excluded. Comparison of the mean latency of the VEP in affected eyes among the three groups was statistically analyzed by a nonparametric independent sample test. RESULTS: Twenty-two patients with acute optic neuritis, 8 patients with recurrent optic neuritis, and 22 patients with ON/MS participated in this study. The mean age among the three groups was not statistically significant. The median value of the latency of flash VEP (fVEP) and pattern reversal VEP (PRVEP) in the acute optic neuritis group was shorter than that of the recurrent optic neuritis group, and statistically significant (fVEP p = 0.012; PRVEP, p = 0.004). The median value of the latency of PRVEP in the acute optic neuritis group was shorter than that of the ON/MS group, and statistically significant (PRVEP p = 0.002). The median value of the latency of both fVEP and PRVEP in the recurrent optic neuritis group and ON/MS group were delayed with no statistical significance (fVEP p = 0.458; PRVEP, p = 0.403). CONCLUSION: The VEP can be used to demonstrate the demyelinating mechanism of optic neuritis and optic neuritis with multiple sclerosis, but cannot determine the susceptibility of the patients with acute ON to become MS. The significantly delayed latency of VEP in recurrent optic neuritis is possibly caused by severe damage of the optic nerve conduction from recurrent attacks.

Repeatability of an automated Landolt C test, compared with the early treatment of diabetic retinopathy study (ETDRS) chart testing.

PURPOSE: To evaluate the repeatability of visual acuity scores from the automated test and compare them with the Early Treatment of Diabetic Retinopathy Study (ETDRS) chart. DESIGN: Instrument validation study based on a model of repeatability study in two observations. SMETHODS: a prospective, clinic-based, comparative study. A total of 206 participants without ocular diseases and refractive errors in their right eyes were randomly enrolled in the automated group in which 107 participants performed the automated test and the ETDRS group in which 99 participants read the ETDRS chart. All participants were tested with only their right eyes without corrections at 4 meters and came back to have the same tests 1 week later. The automated test used the Landolt rings as optotypes and was conducted by a low-ended personal computer with a 15-inch monitor and a wireless keyboard. The "letter" score calculated by counting every correct response to optotypes, and the "threshold curve" score interpreted from the optotype size at the midpoint of a visual acuity threshold curve. RESULTS: The 95% confidence interval of test-retest of visual acuity scores from the automated test are comparable to the ETDRS chart (.143 compared with.125 for letter scores,.145 compared with.122 for threshold curve scores). The score repeatabilities, calculated from the standard deviations of test-retest, from the automated test are also comparable to the ETDRS chart (.201 compared with.177 for letter scores,.206 compared with.172 for threshold curve scores). All comparisons demonstrated no statistical difference (P >.05). CONCLUSIONS: The automated testing system in this study enables practical measuring visual acuity by the Landolt rings. The system's repeatability, which is comparable to the ETDRS chart, supports its role as an alternative tool for measuring outcome in new clinical research. Its ability to practically generate visual acuity threshold curves may also be useful in future clinical research studies.